Electromyography biofeedback therapy for spinal cord injury rehabilitation: a systematic review.
Frontiers in neurology · 2026
Abstract originale
BACKGROUND: Electromyographic biofeedback (EMG-BF) is being increasingly used as an adjunct to rehabilitation after spinal cord injury (SCI), but the available evidence is limited by the small sample size, heterogeneous comparators, and variable outcome reporting. We aimed to systematically identify and narratively synthesize the evidence on the effects of EMG-BF in SCI rehabilitation. METHODS: We searched the PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wanfang, VIP and other databases from inception to 8 January 2026. Two reviewers independently screened records, extracted data and assessed the risk of bias using the Cochrane RoB 2 tool. Because of substantial clinical and methodological heterogeneity and inconsistent outcome-data types, we did not pool effect estimates; instead, we performed a structured synthesis without meta-analysis (SWiM) and graded the certainty of evidence using GRADE. RESULTS: Ten randomized controlled trials (RCTs) involving 537 participants were included. All 10 studies reported a favorable direction of effect for EMG-BF, but the evidence for every outcome was of low or very low certainty. Across the five RCTs reporting surface electromyography (sEMG), all reported larger signal amplitudes in the EMG-BF arm, although the outcome data types varied (means vs. medians) and the muscle sites and comparators differed. Two RCTs reported greater lower-limb muscle strength with EMG-BF. One RCT reported a higher functional independence measure score, and two reported higher ASIA motor scores with the use of the EMG-BF. Four RCTs reported reduced spasticity (modified Ashworth scale, MAS), but MAS was reported inconsistently as ordinal grade distributions or as grade-derived scores, precluding any pooled estimate. Three RCTs reported higher Berg balance scale scores with the use of the EMG-BF. Only one pilot RCT reported pain, and it permitted only within-group comparisons. CONCLUSION: Low- to very-low-certainty evidence suggests that EMG-BF may improve sEMG signals, lower-limb muscle strength, functional independence, ASIA motor scores, spasticity and balance in patients with SCI, but these findings are preliminary. Large, well-designed RCTs with allocation concealment, blinding of outcome assessors, standardized comparators and prospective registration are needed. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261282923, Identifier: [CRD420261282923].
Parole chiave
Leggi il testo integrale originale
Testo estratto dalla pubblicazione: sono esclusi immagini, media, supplementi e parti soggette a diritti distinti.
Electromyography biofeedback therapy for spinal cord injury rehabilitation: a systematic review
Background
Electromyographic biofeedback (EMG-BF) is being increasingly used as an adjunct to rehabilitation after spinal cord injury (SCI), but the available evidence is limited by the small sample size, heterogeneous comparators, and variable outcome reporting. We aimed to systematically identify and narratively synthesize the evidence on the effects of EMG-BF in SCI rehabilitation.
Methods
We searched the PubMed, Embase, Cochrane Library, Web of Science, CNKI, Wanfang, VIP and other databases from inception to 8 January 2026. Two reviewers independently screened records, extracted data and assessed the risk of bias using the Cochrane RoB 2 tool. Because of substantial clinical and methodological heterogeneity and inconsistent outcome-data types, we did not pool effect estimates; instead, we performed a structured synthesis without meta-analysis (SWiM) and graded the certainty of evidence using GRADE.
Results
Ten randomized controlled trials (RCTs) involving 537 participants were included. All 10 studies reported a favorable direction of effect for EMG-BF, but the evidence for every outcome was of low or very low certainty. Across the five RCTs reporting surface electromyography (sEMG), all reported larger signal amplitudes in the EMG-BF arm, although the outcome data types varied (means vs. medians) and the muscle sites and comparators differed. Two RCTs reported greater lower-limb muscle strength with EMG-BF. One RCT reported a higher functional independence measure score, and two reported higher ASIA motor scores with the use of the EMG-BF. Four RCTs reported reduced spasticity (modified Ashworth scale, MAS), but MAS was reported inconsistently as ordinal grade distributions or as grade-derived scores, precluding any pooled estimate. Three RCTs reported higher Berg balance scale scores with the use of the EMG-BF. Only one pilot RCT reported pain, and it permitted only within-group comparisons.
Conclusion
Low- to very-low-certainty evidence suggests that EMG-BF may improve sEMG signals, lower-limb muscle strength, functional independence, ASIA motor scores, spasticity and balance in patients with SCI, but these findings are preliminary. Large, well-designed RCTs with allocation concealment, blinding of outcome assessors, standardized comparators and prospective registration are needed.
Systematic review registration
https://www.crd.york.ac.uk/PROSPERO/view/CRD420261282923, Identifier: [CRD420261282923].
Highlights
Spinal cord injury (SCI) often leads to partial or complete loss of function below the level of injury, significantly impacting quality of life.
Electromyographic biofeedback (EMG-BF) can improve specific clinical outcomes following SCI.
Because of heterogeneous comparators and inconsistent outcome data types, we synthesized the evidence narratively (SWiM) rather than by meta-analysis.
Low- to very-low-certainty evidence suggests that the EMG-BF may improve sEMG signals, muscle strength, functional independence, ASIA motor scores, spasticity and balance in patients with SCI.
1Introduction
Spinal cord injury (SCI) is a neurological disorder that affects 250,000 to 500,000 individuals globally each year and often leads to partial or complete loss of function below the level of injury, significantly impacting quality of life (1). The restoration of walking ability is a primary concern for many patients. Prognosis for walking function is primarily associated with injury severity (ASIA Impairment Scale [AIS] classification) and the neurological level of injury, together with the preservation of descending motor pathways, residual voluntary muscle strength and sensorimotor integrity (2, 3). Electromyography biofeedback therapy (EMG-BF) is an active, conscious rehabilitation technique that provides patients with real-time feedback of muscle electrical activity, usually in visual or auditory form, to promote muscle contraction and facilitate motor relearning (4).
Previous studies have shown that electromyographic biofeedback electrical stimulation (EMG-BFES) can improve specific clinical outcomes following SCI, including muscle activation, muscle strength, spasticity scores, selected functional performance measures and pain scores (5, 6). Functional impairment after SCI is multifaceted, and the outcomes examined in this review pertain primarily to motor and functional domains, together with spasticity and pain. However, few small-sample, single-center trials (sample sizes < 50) and multicenter RCTs have been conducted to validate the long-term efficacy of these treatments. This study aims to systematically integrate existing research and provide a structured narrative synthesis of the efficacy of EMG-BF in the rehabilitation of patients with SCI, with the goal of providing evidence and guidance for future clinical practice and research.
2Materials and methods
2.1Search strategy
Comprehensive computerized searches were conducted in PubMed, Embase, Web of Science, the Cochrane Library, CNKI, Wanfang, and the VIP Chinese Science and Technology Journal Database from the inception of each database to 8 January 2026. Both Chinese and English search terms were used, and the full search strategies for each database are provided in the Supplementary materials. The reference lists of the included studies were also screened to identify additional relevant studies.
2.2Inclusion and exclusion criteria
Studies were included if they met all of the following criteria: (1) a randomized controlled trial (RCT) design; (2) participants with a clinical diagnosis of SCI; (3) EMG biofeedback as the experimental intervention, alone or added to conventional rehabilitation; (4) at least one outcome within the review scope was reported; and (5) the full text was available.
Studies were excluded if they met any of the following criteria: (1) nonrandomized study designs (including quasiexperimental, time-sequential or historical-control designs and crossover trials that did not evaluate EMG-BF against a control intervention); (2) reviews, case reports, conference abstracts or other nonprimary research; (3) duplicate publications of the same patient cohort; and (4) studies whose outcomes fell outside the scope of the review. Study eligibility was determined strictly according to these predefined criteria and was not influenced by the effect of any individual study on the results.
2.3Data extraction
Two researchers independently screened the literature, extracted the data and crosschecked the findings, with disagreements resolved through discussion or third-party consultation. The data extracted included (1) basic information such as the first author, publication year and sample size; (2) patient characteristics such as age, sex, injury severity, injury location and duration of illness; and (3) intervention details, including the EMG-BF protocol (frequency, intensity, duration) and conventional rehabilitation content. Every extracted value was recorded together with its source location in the primary report so that each number in the synthesis was traceable to its source.
2.4Outcome measures
The outcomes of interest were surface electromyography (sEMG) of the lower-limb muscles, manual muscle testing of lower-limb muscle strength (quadriceps, hamstrings and tibialis anterior), the Functional Independence Measure (FIM), the American Spinal Injury Association (ASIA) motor score, the Modified Ashworth Scale (MAS), the Berg Balance Scale (BBS) and validated pain rating scales. All outcome measures are instruments validated for, and routinely applied in, the SCI population.
2.5Risk of bias assessment
The risk of bias of the included randomized controlled trials was assessed using the revised Cochrane risk-of-bias tool for randomized trials (RoB 2) (7), which evaluates five domains: bias arising from the randomization process; bias due to deviations from the intended interventions; bias due to missing outcome data; bias in measurement of the outcome; and bias in selection of the reported result. Two reviewers independently assessed each study, and disagreements were resolved through discussion or consultation with a third reviewer. The results are presented as a traffic-light plot (Figure 1) and in Supplementary Table S1, which records the domain-level judgments and their supporting quotations for each study.
2.6Synthesis methods
Quantitative pooling was judged to be inappropriate after complete re-extraction and verification of the primary data. The reasons were (1) marked clinical heterogeneity in study populations, outcome definitions and intervention protocols; (2) methodological heterogeneity in the comparators, which ranged from conventional rehabilitation alone to several different active alternatives; and (3) inconsistent outcome-data types, most notably the Modified Ashworth Scale, which was reported as ordinal grade distributions in some studies and as grade-derived numeric scores in others, and sEMG and muscle strength, which were reported as medians (interquartile ranges) in one study and as the means (SD) in others. We therefore performed a structured synthesis without meta-analysis, reported according to the Synthesis Without Meta-analysis (SWiM) guidelines (8).
Within each outcome, studies were grouped by comparator type (conventional rehabilitation versus active comparator), and for each study, we reported the direction of effect (whether EMG-BF was favored), whether the difference was reported as statistically significant, the outcome-data type, and the risk-of-bias context. We did not compute or report any pooled effect estimates, and no forest plots are presented.
2.7Certainty of evidence
The certainty of the evidence for each outcome was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach (9, 10). Evidence from randomized trials was initially rated as high certainty and was downgraded by one or two levels for each of five domains: risk of bias, inconsistency, indirectness, imprecision and publication bias. Two reviewers independently applied the GRADE criteria, and disagreements were resolved by discussion. Because no pooled estimates were computed, the summary-of-findings table (Table 1) reports the number of studies and participants, the certainty rating, and a narrative summary of the direction and consistency of findings, rather than an effect size.
Table 1Basic characteristics of the included studies (n = 10).
Author and year Study design Research subjects Sample size (E/C) Experimental group Control group Outcome indicator
He et al. 2011 (11) RCT (random number table) Patients with spinal cord injury 35/35 Electromyographic biofeedback training added to the control group Conventional rehabilitation + medium-frequency electrotherapy (active) ① sEMG; ④ ASIA motor score
Middaugh et al. 2013 (12) RCT (pilot) SCI, C6 or below, manual wheelchair users, shoulder pain 8/7 EMG biofeedback added to exercise Home-based standard exercise programme ⑦ Pain (within-group only)
Govil and Noohu (2013) (13) RCT (pretest–posttest) Incomplete SCI, WISCI ≥6, 18–50 y, ≥1 y post-injury 30 (per-group n not reported) Gluteus maximus EMG biofeedback added to conventional rehab + gait training Conventional rehabilitation + gait training ① sEMG
Shi et al. (2014) (14) RCT SCI after surgery, ankle dorsiflexion dysfunction 15/15 EMG biofeedback electrical stimulation added to the control group Ankle-foot orthosis (90°) + conventional rehabilitation ① sEMG; ② lower-limb muscle strength‡
Hu et al. (2016) (15) RCT Incomplete thoracolumbar SCI 30/30 EMG biofeedback added to conventional rehabilitation Conventional rehabilitation ① sEMG; ③ FIM; ④ ASIA motor score
Xie and Ma (2019) (16) RCT (random number table) SCI with lower-limb spasticity 27/27 EMG biofeedback added to conventional rehabilitation Conventional rehabilitation ⑤ MAS (ordinal n(%))
Gong et al. (2021) (17) RCT (three-arm) SCI with lower-limb spasticity 40/40/40 (A/B/C) A: EMG biofeedback + suspension exercise; B: EMG biofeedback C: suspension exercise (active) ⑤ MAS; ⑥ BBS; FAC; CSS; Fugl-Meyer
Guo et al. (2021) (18) RCT (block randomisation) Incomplete paraplegia, quadriceps < grade 3, >6 mo post-injury, <60 y 40 randomised (33 analysed) EMG biofeedback added to conventional physiotherapy Conventional physiotherapy ① sEMG (median, IQR)
Yang et al. (2023) (19) RCT (random number table) Patients with spinal cord injury 21/21 EMG biofeedback electrical stimulation (incl. Pelvic-floor stimulation) added to conventional rehab Conventional rehabilitation ⑤ MAS; ⑥ BBS; LMES; 10MWT
Chen et al. (2024) (20) RCT (random number table) Patients with spinal cord injury 38/38 EMG biofeedback added to core-stability training Core-stability training on unstable surfaces (active) ⑤ MAS; ⑥ BBS; FAC; FMA; BI
① Surface electromyography (sEMG); ② lower limb muscle strength; ③ Functional Independence Measure (FIM); ④ ASIA Motor Scale; ⑤ Modified Ashworth Scale (MAS); ⑥ Berg Balance Scale (BBS); ⑦ pain score. Active comparators are marked in bold. All included studies were randomized controlled trials (RCTs).
Active comparators are marked in bold. Govil and Noohu (13) reported a total of 30 participants but did not state the number per group. Guo et al. (18) randomised 40 participants and analysed 33; the per-outcome participant counts in Table 1 use the analysed number. ‡Shi et al. (14) reported a muscle-strength value (1.04 ± 1.38 → 4.20 ± 0.82) that is implausible for the 0–5 grade scale and is identical to the tibialis-anterior sEMG value in Hu et al. (15); this is flagged as a data concern in the synthesis.
3Results
3.1Literature search results
A systematic search of PubMed, Embase, the Cochrane Library, Web of Science, CNKI, Wanfang and VIP from database inception to 8 January 2026 identified 1,286 records (1,211 from databases and 75 from registers). After removing 452 records before screening (422 duplicates, 16 records marked as ineligible by automation tools, and 14 records removed for other reasons), 834 records underwent title and abstract screening, of which 627 were excluded. The full text of 207 reports was sought for retrieval; 5 reports could not be retrieved, and 202 reports were assessed for eligibility. Of these 202 reports, 192 were excluded and 10 randomized controlled trials (11–20) were included in the review. The 192 exclusions comprised 59 reports with inadequate study design (non-RCTs, case reports and other non-primary designs), 78 with incomplete or unobtainable data, 43 with an ineligible study population, 6 duplicate publications, 5 without relevant outcome measures, and 1 in which EMG biofeedback was the comparator rather than the intervention. Six of these exclusions were made during the present revision after re-application of the prespecified criteria: three non-randomized trials (21–23), one in which EMG biofeedback was the comparator rather than the intervention (24), one whose outcomes were outside the review’s scope (25), and one duplicate report of the same cohort as an included study (26). The study selection process is presented in the PRISMA 2020 flow diagram (Figure 2).
3.2Basic characteristics of the included studies
As detailed in Table 2, the 10 included RCTs included patients with SCI, with sample sizes ranging from 15 to 120 participants. In every included study, the experimental group received EMG biofeedback, alone or in combination with the control intervention. The comparator conditions were heterogeneous and fell into two broad groups:
Conventional rehabilitation (usual-care comparator): Hu et al. (15), Yang and Wu (19), Xie and Ma (16), Shi et al. (14), Guo et al. (18), Govil and Noohu (13), and Middaugh et al. (12).
Active comparators: He et al. (11), Chen and Zhang (20), and Gong and Zhang (17).
Table 2Summary of findings: electromyography biofeedback (EMG-BF) added to rehabilitation for functional outcomes after spinal cord injury (structured synthesis without meta-analysis).
Outcome Studies (participants) Certainty of evidence (GRADE) Narrative summary of findings
Surface electromyography (sEMG) 5 (223) ⊕⊝⊝⊝ Very low All 5 RCTs reported larger sEMG signal in the EMG-BF arm than in control; direction was consistent, but studies pooled heterogeneous muscle sites, several used different comparators, one reported median (IQR), and all were at some concern of bias. Downgraded for risk of bias, indirectness and imprecision.
Lower-limb muscle strength 2 (63) ⊕⊝⊝⊝ Very low Two RCTs reported greater strength with EMG-BF; one reported median (IQR), and one reported an implausible grade-scale value identical to another study’s sEMG value. Downgraded for risk of bias, indirectness and imprecision.
Functional Independence Measure (FIM) 1 (60) ⊕⊝⊝⊝ Very low A single RCT reported a higher FIM score with EMG-BF; the estimate is from one small study at some concern of bias and is imprecise. Downgraded for risk of bias and imprecision.
ASIA motor score 2 (130) ⊕ ⊕ ⊝⊝ Low Two RCTs reported a higher ASIA motor score with EMG-BF; direction consistent but based on two small studies at some concern of bias. Downgraded for risk of bias.
Modified Ashworth Scale (MAS) 4 (292) ⊕⊝⊝⊝ Very low MAS is ordinal; two RCTs reported grade distributions n(%), two reported grade-derived scores as mean ± SD. All reported reduced spasticity with EMG-BF, but the inconsistent data type precludes any pooled estimate. Downgraded for risk of bias, indirectness and imprecision.
Berg Balance Scale (BBS) 3 (238) ⊕ ⊕ ⊝⊝ Low Three RCTs reported higher balance scores with EMG-BF; direction consistent but small samples at some concern of bias. Downgraded for risk of bias and imprecision.
Pain 1 (15) ⊕⊝⊝⊝ Very low A single pilot RCT reported only within-group comparisons; no between-group effect could be estimated. Downgraded for risk of bias, indirectness and imprecision.
Population: adults with spinal cord injury. Intervention: EMG biofeedback added to rehabilitation. Comparison: conventional rehabilitation or another non-EMG-BF control. Because of clinical and methodological heterogeneity and inconsistent outcome-data types, outcomes are synthesised narratively (SWiM); no pooled effect estimates are reported.
GRADE certainty of evidence: ⊕ ⊕ ⊕ ⊕ High; ⊕ ⊕ ⊕⊝ Moderate; ⊕ ⊕ ⊝⊝ Low; ⊕⊝⊝⊝ Very low. Reasons for downgrading: risk of bias (all studies at ‘some concerns’ on RoB 2, with allocation concealment and blinding unreported in almost all studies); indirectness (sEMG and muscle strength are surrogate body-function measures, not patient-important outcomes); imprecision (small samples below the optimal information size). Publication bias was not formally assessed because every outcome included fewer than 10 studies. ASIA, American Spinal Injury Association; BBS, Berg Balance Scale; FIM, Functional Independence Measure; MAS, Modified Ashworth Scale; RoB 2, Cochrane risk-of-bias tool for randomised trials, version 2; sEMG, surface electromyography; SWiM, Synthesis Without Meta-analysis.
This heterogeneity of the comparator is examined in the Discussion section. The outcome measures included (1) sEMG, (2) lower-limb muscle strength, (3) FIM, (4) ASIA motor score, (5) MAS for spasticity, (6) BBS, and (7) pain. Adverse events were not reported consistently across the included studies; therefore, this review makes no claim regarding the safety of the EMG-BF.
3.3Risk of bias
The risk of bias was independently assessed by two reviewers. All 10 included studies were randomized controlled trials and were assessed with the Cochrane RoB 2 tool. None of the 10 RCTs were judged to be at low risk of bias overall: all 10 were rated as having some concerns, and no RCT was rated at high risk in any domain (Figure 1; Supplementary Table S1).
Randomization process (D1): Of the 10 RCTs, eight described a specific method for generating the random allocation sequence (random number table, computer-generated sequence, or block randomization), whereas two stated only that participants were randomized without describing how. Only one study, Guo et al. (18), was judged at low risk for this domain because it described block randomization performed by a specialist who was not involved in the intervention or assessments, together with consecutively numbered sealed envelopes for allocation concealment and balanced baseline characteristics. The remaining nine RCTs were judged as having some concerns, predominantly because allocation concealment was not reported; a baseline imbalance in ASIA impairment grade between groups was noted in Govil and Noohu (13).
Deviations from intended interventions (D2): All 10 RCTs were rated as having some concerns. The interventions were behavioral and physical rehabilitation programmes in which participants and personnel cannot readily be blinded, and no study reported the blinding of participants or personnel.
Missing outcome data (D3): Eight RCTs were judged to be low risk because the outcome data were reported for the same number of participants as were randomized, and no losses were described. Two RCTs were rated as having some concerns: Guo et al. (18) recruited 40 participants but analyzed only 33 participants without explaining the 7 missing participants, and Govil and Noohu (13) did not clearly report the number per group.
Measurement of the outcome (D4): One RCT (Govil and Noohu, (13)) was judged at low risk because its outcomes were objective, instrument-measured quantities. The remaining nine RCTs were rated as having some concerns because the outcome was subjective or semisubjective (pain rating scales, MAS, BBS, FIM, or manual muscle-grading scales), and blinding of the outcome assessor was not reported.
Selection of the reported result (D5): Only Guo et al. (18) was judged to be at low risk because the trial was prospectively registered (ChiCTR1800018891). The other nine RCTs were rated as having some concerns because they reported no prospective registration or published protocol.
In summary, all 10 included studies carried at least some concerns of bias, and no study was at a low risk of bias overall. This limits the certainty of the evidence, as reflected in the results of the GRADE assessment (Table 1).
3.4Surface electromyography (sEMG)
Five RCTs reported sEMG outcomes (He et al. (11); Govil and Noohu (13); Shi et al. (14); Hu et al. (15); Guo et al. (18)). All five reported a larger sEMG signal in the EMG-BF arm than in the control arm; thus, the direction of the effect was consistent across studies. However, the studies differed in the muscle sites measured (gluteus maximus, quadriceps femoris, and tibialis anterior), in the comparator used, and in the outcome-data type: four studies reported means (SD), whereas Guo et al. (18) reported medians (25th, 75th percentiles), which could not be combined with the mean-based results. Two studies warrant particular caution: Govil and Noohu (13) reported internally inconsistent cadence values across their tables and did not report the number of participants per group, and He et al. (11) used an active comparator (medium-frequency electrotherapy) rather than conventional rehabilitation alone. For example, He et al. (2011) (11) reported that the quadriceps femoris sEMG signal increased from 65.9 ± 11.8 μV to 131.5 ± 19.3 μV in the EMG-BF group, whereas it increased from 72.6 ± 14.3 μV to 84.3 ± 19.1 μV in the medium-frequency electrotherapy control group (p < 0.05). Taken together, the sEMG evidence consistently favors the EMG-BF but is of very low certainty.
3.5Lower-limb muscle strength
Two RCTs reported lower limb muscle strength (Shi et al. (14); Guo et al. (18)). Both reported greater muscle strength with EMG-BF. Guo et al. (18) reported the median (IQR) muscle strength. Shi et al. (14) reported that Lovett-graded muscle strength improved from 1.04 ± 1.38 to 4.20 ± 0.82 in the EMG-BF group versus 1.64 ± 1.47 to 3.10 ± 0.40 in the control group; this value should be interpreted cautiously because it is implausible for a 0–5 grade scale and is identical to the tibialis-anterior sEMG value reported in Hu et al. (15), raising a concern of mislabeling. The evidence of muscle strength is therefore very low certainty.
3.6Functional Independence measure (FIM)
A single RCT (Hu et al. (15)) reported FIM, with the EMG-BF group improving from 54.82 ± 8.35 to 92.07 ± 9.25 (8 weeks) and 109.5 ± 13.82 (12 weeks). This is a single small study with some concern of bias, and the FIM evidence has very low certainty.
3.7ASIA motor score
Two RCTs reported ASIA motor scores (Hu et al. (15); He et al. (11)). Both reported higher ASIA motor scores with the use of EMG-BF. Hu et al. (15) reported that the ASIA motor score improved from 11.48 ± 7.08 to 28.12 ± 11.28 (8 weeks) and 39.76 ± 13.45 (12 weeks) in the EMG-BF group. He et al. (11) reported that the ASIA motor score improved from 26.75 ± 5.07 to 32.65 ± 5.22 in the EMG-BF group versus 25.10 ± 4.26 to 28.50 ± 4.46 in the medium-frequency electrotherapy control group (p < 0.01 between groups). The two studies were consistent in direction but small and at some level of concern of bias, indicating low certainty of the evidence. He et al. (11) reported a psychological outcome (Rosenberg Self-Esteem Scale, RSES) that falls outside the motor and functional scope of this review; it improved in the EMG-BF group (18.3 ± 1.7 to 20.6 ± 2.5, p < 0.05) but not in the control group and correlated with the ASIA motor score in the EMG-BF group (r = 0.692, p < 0.01).
3.8Modified Ashworth scale (MAS)
Four RCTs reported MAS for spasticity (Xie and Ma (16); Gong and Zhang (17); Yang and Wu (19); Chen and Zhang (20)). All four studies reported reduced spasticity with EMG-BF, so the direction of the effect was consistent. Critically, however, MAS has been reported inconsistently across studies: Xie and Ma (16) and Chen and Zhang (20) reported ordinal grade distributions (n, %), whereas Gong and Zhang (17) and Yang and Wu (19) converted grades to numeric scores and reported means (SD). Because MAS is an ordinal scale, none of these reports are suitable for combining into a continuous mean difference, and no pooled estimate was computed. Notably, in the three-arm trial by Gong and Zhang (17) in 2021, the MAS reduction was greater in the combined EMG-BF-plus-suspension arm (3.65 ± 0.34 → 2.15 ± 0.35) than in the suspension-only arm (3.60 ± 0.31 → 3.00 ± 0.20), indicating that compared with suspension exercise alone, adding EMG-BF to suspension exercise resulted in a greater reduction in spasticity. Because the comparator was itself an active intervention, these findings support an additional benefit of EMG-BF relative to an active alternative for spasticity. The MAS evidence is very low certainty.
3.9Berg balance scale (BBS)
Three RCTs reported BBS (Gong and Zhang (17); Yang and Wu (19); Chen and Zhang (20)). All three reported higher balance scores with the use of the EMG-BF. In Gong and Zhang (17), BBS improved more in the EMG-BF-plus-suspension arm (35.65 ± 3.45 → 46.75 ± 4.28) than in the suspension-only arm (35.80 ± 3.28 → 41.60 ± 3.84); however, the point estimate for the EMG-BF-only arm versus the suspension arm was near zero, indicating little additional balance benefit of the EMG-BF over an active alternative. Yang and Wu (19) and Chen and Zhang (20) reported higher BBS in the EMG-BF arm than in the control arm did. The BBS evidence is low certainty.
3.10Pain
A single pilot RCT (Middaugh et al. (12), n = 15) reported pain using the Wheelchair Users Shoulder Pain Index, but the authors reported only within-group comparisons (“allowed only within-group comparisons”); thus, no between-group effect of EMG-BF on pain could be estimated. The evidence of pain is very low certainty.
3.11Certainty of evidence
The certainty of the evidence was graded as low or very low for all seven outcomes; no outcome reached moderate or high certainty (Table 1). The main reasons for downgrading were consistent across outcomes:
Risk of bias: All 10 RCTs (11–20) were at some concern of bias, with allocation concealment and blinding unreported in almost all the studies.
Indirectness: sEMG and muscle strength are surrogate body function measures rather than patient-important outcomes, and several comparators were active interventions rather than conventional rehabilitation.
Imprecision: Every outcome was based on one to five small studies, with total sample sizes well below the optimal information size.
Publication bias was not formally assessed because every outcome included fewer than 10 studies, a threshold below which funnel-plot asymmetry and regression tests are unreliable. Taken together, the available evidence provides only low to very low certainty that electromyography biofeedback therapy improves the reported outcomes, and this should be borne in mind when interpreting the results.
4Discussion
It was once believed that the central nervous system (CNS) has minimal regenerative capacity (27). However, recent studies have demonstrated that connections between CNS cells undergo continuous modification and refinement throughout life and that latent pathways and synapses can act as reserves that may be activated through targeted training (27). Axonal sprouting and growth are generally more pronounced in incomplete SCI (28). Clinical studies suggest that EMG-BF may enhance CNS plasticity and promote neural synapse regeneration (29–31), although much of this mechanistic evidence is derived from preclinical models and small clinical series, and its therapeutic relevance is clearest for individuals with incomplete injury who retain some descending motor pathways. The present review was conducted to integrate the available clinical evidence on the effects of EMG-BF in patients with SCI.
EMG-BF has been increasingly used for functional rehabilitation after SCI (18). As early as 2001, Petrofsky (32) highlighted EMG-BF as a rehabilitation technique for neurological disorders, including SCI. The clinical evidence, however, is mixed and often derived from small studies. For example, in a randomized trial excluded from the present review because EMG biofeedback was the comparator rather than the intervention (24), EMG biofeedback relaxation training and self-hypnosis training produced similar reductions in chronic pain, and a statistically significant reduction was observed in the self-hypnosis arm rather than the biofeedback arm—a finding that cautions against attributing benefit to biofeedback beyond the effects of an active comparator (33, 34). Jiang et al. (35) reported that EMG-BF improves neurogenic bladder function in patients with SCI; De Biase et al. (39) reported an enhanced voluntary response of the rectus femoris; Yang and Wu (19) reported that EMG-BF electrical stimulation improves lower-limb function and walking ability; and Govil and Noohu (13) reported that adding gluteus maximus EMG-BF to conventional rehabilitation improved gait parameters. In the present synthesis, all included studies reported a favorable direction of effect for EMG-BF across the motor, functional, spasticity and balance outcomes examined.
The findings for the individual outcomes are nonetheless preliminary. With respect to sEMG, all five contributing studies (11, 13–15, 18) reported larger signal amplitudes with EMG-BF, but the studies pooled heterogeneous muscle sites and used different comparators and mixed mean-based and median-based reporting; thus, the effect could not be quantified reliably. With respect to muscle strength, FIM and pain, the evidence is based on one or two small studies, one of which, Middaugh et al. (12), reported only within-group comparisons; thus, no between-group effect could be estimated for pain. For MAS, the outcome data type was inconsistent across studies, and the three-arm trial by Gong and Zhang (17) suggested that EMG-BF may not confer additional benefit over an active alternative for spasticity.
The most important limitation of this evidence base is the heterogeneity of the control conditions. Although the eligibility criteria required conventional rehabilitation as the comparator, the actual comparator arms ranged from conventional rehabilitation alone to several different active alternatives, including medium-frequency electrotherapy, core-stability training and suspension exercise. This means that the available studies estimate the advantage of EMG-BF over a heterogeneous blend of therapies rather than over no treatment or usual care alone, and it is a principal reason why quantitative pooling was not appropriate. A second important limitation is the reliability of the primary data: During the revision, we re-extracted all the outcomes and corrected several coding problems that affected the earlier analysis, including a reversal of treatment and comparator groups in one study, the treatment of ordinal MAS grades and of median (IQR) data as the means (SD), and an implausible muscle strength value identical to another study’s sEMG value. These problems, together with the near-universal absence of allocation concealment and blinding and the small sample sizes, carry a genuine risk of bias and limit the internal validity of any quantitative estimate.
EMG-BF is also useful in the context of other adjunctive neurorehabilitation technologies for SCI. Functional electrical stimulation (FES), repetitive transcranial magnetic stimulation (rTMS) and robot-assisted gait training have been evaluated in randomized trials and pooled analyses, with effect sizes broadly comparable in magnitude to those reported here for EMG-BF (36–38). Direct quantitative comparison is precluded by differences in populations, outcome measures and comparator conditions, but the EMG-BF appears to belong to a family of adjunctive, low-risk interventions that produce modest-to-moderate gains when added to conventional rehabilitation. Whether EMG-BF is superior, equivalent or inferior to these alternatives remains an open question requiring head-to-head trials, and our findings therefore support the use of EMG-BF as one available option rather than a clearly preferred therapy.
Publication bias could not be formally assessed for any outcome because every outcome included fewer than 10 studies. This limitation is inherent to a field dominated by small, single-center trials and should be weighed when interpreting the results. This review has several further limitations: most included studies were conducted in a single country (China), and several narrowly selected subgroups (e.g., incomplete thoracolumbar injuries, lower-limb spasticity, or shoulder pain in manual wheelchair users) were included, limiting generalisability; intervention parameters—treatment duration, session frequency, intensity, target muscles and device type—varied substantially across studies; and electromyographic signals are inherently susceptible to electrode placement and signal-processing artifacts. Collectively, these shortcomings mean that the present findings should be regarded as hypothesis-generating and supportive of — but not definitive for — the routine clinical use of EMG-BF, pending larger, multicenter, adequately concealed RCTs with standardized comparators and outcomes.
5Conclusion
Low- to very-low-certainty evidence suggests that EMG-BF may improve sEMG signals, lower-limb muscle strength, functional independence, ASIA motor scores, spasticity and balance in patients with SCI. Because every included study was judged to be at some risk of bias, most outcomes were based on only one to four small studies, and the comparator conditions were highly heterogeneous; these findings should be interpreted with caution rather than as established benefits. EMG-BF is noninvasive and easy to administer and may be considered a promising adjunct to conventional rehabilitation; however, its effectiveness remains to be confirmed by higher-certainty evidence. Future research should include large, multicenter randomized controlled trials with adequate allocation concealment, blinding of outcome assessors, standardized comparators and prospective registration and should further develop closed-loop intelligent feedback systems integrating electromyographic signals with electroencephalography (EEG) and functional near-infrared spectroscopy (fNIRS) to determine optimal treatment parameters and intervention cycles for EMG-BF.
References
1.Izzy S . Traumatic spinal cord injury . Continuum (Minneap Minn) . (2024 ) 30 :53 –72 . doi: 10.1212/CON.0000000000001392 , 38330472 PMC10869103
2.Cao L Ou J Zhang M Wang X Sheng C Tan X . Early predictors of walking recovery in patients after traumatic spinal cord injury: a systematic review and meta-analysis . J Neurotrauma . (2026 ). doi: 10.1177/08977151251407646 41700668
3.Scivoletto G Tamburella F Laurenza L Torre M Molinari M . Who is going to walk? A review of the factors influencing walking recovery after spinal cord injury . Front Hum Neurosci . (2014 ) 8 :141 . doi: 10.3389/fnhum.2014.00141 , 24659962 PMC3952432
4.Massaferri R Calvo APC Coutinho ABB Guimarães TT Farinatti P . Optimizing muscle activation in cadets using electromyography biofeedback during anti-G training . Aerosp Med Hum Perform . (2025 ) 96 :985 –92 . doi: 10.3357/AMHP.6714.2025 , 41253371
5.Li G Doman C Suresh NL . Increase in muscle activation during physiotherapy with electromyography biofeedback for patients with acute cervical spinal cord injuries . Annu Int Conf IEEE Eng Med Biol Soc . (2019 ) 2019 :5121 –4 . doi: 10.1109/EMBC.2019.8856982 31947011
6.Cheung EYY Yu KKK Kwan RLC Ng CKM Chau RMW Cheing GLY . Effect of EMG-biofeedback robotic-assisted body weight supported treadmill training on walking ability and cardiopulmonary function on people with subacute spinal cord injuries - a randomized controlled trial . BMC Neurol . (2019 ) 19 :140 . doi: 10.1186/s12883-019-1361-z , 31234791 PMC6591819
7.Sterne JAC Savović J Page MJ Elbers RG Blencowe NS Boutron I . RoB 2: a revised tool for assessing risk of bias in randomized trials . BMJ . (2019 ) 366 :l4898 . doi: 10.1136/bmj.l4898 31462531
8.Campbell M McKenzie JE Sowden A Katikireddi SV Brennan SE Ellis S . Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline . BMJ . (2020 ) 368 :l6890 . doi: 10.1136/bmj.l6890 , 31948937 PMC7190266
9.Guyatt GH Oxman AD Vist GE Kunz R Falck-Ytter Y Alonso-Coello P . GRADE: an emerging consensus on rating quality of evidence and strength of recommendations . BMJ . (2008 ) 336 :924 –6 . doi: 10.1136/bmj.39489.470347.AD , 18436948 PMC2335261
10.Schünemann H Brożek J Guyatt G Oxman A . GRADE Handbook for Grading Quality of Evidence and Strength of Recommendations .The GRADE Working Group (2013 ). Available online at: https://gdt.gradepro.org/app/handbook/handbook.html
11.He H Dai GY Liu Y Wang HB . Effects of electromyographic biofeedback training on psychological and motor functions in spinal cord injury patients . Chin J Phys Med Rehabil . (2011 ) 33 :762 –5 . doi: 10.3760/cma.j.jssn.0254-1424.2011.010.011
12.Middaugh S Thomas KJ Smith AR McFall TL Klingmueller J . EMG biofeedback and exercise for treatment of cervical and shoulder pain in individuals with a spinal cord injury: a pilot study . Top Spinal Cord Inj Rehabil . (2013 ) 19 :311 –23 . doi: 10.1310/sci1904-311 , 24244096 PMC3816725
13.Govil K Noohu MM . Effect of EMG biofeedback training of gluteus maximus muscle on gait parameters in incomplete spinal cord injury . NeuroRehabilitation . (2013 ) 33 :147 –52 . doi: 10.3233/NRE-130939 , 23949032
14.Shi XX Tang JS Qin J Hu Y Cao JJ Hou SX . Efficacy of electromyographic biofeedback therapy combined with ankle-foot orthoses in treating postoperative dorsiflexion dysfunction in spinal cord injury patients . Chin J Bone Joint . (2014 ) 3 :661 –4 . doi: 10.3969/j.issn.2095-252X.2014.09.006
15.Hu KH Chang YJ Yang TY Zhang Y Tian Y Li YA . Effects of electromyographic biofeedback combined with rehabilitation training on motor function and functional independence in patients with spinal cord injury . Chin J Rehabil Med . (2016 ) 31 :450 –2 . doi: 10.3870/zgkf.2016.06.013
16.Xie SS Ma RH . Observation on the effect of electromyographic biofeedback therapy in treating lower limb spasticity in spinal cord injury patients . Med J Chin People Health . (2019 ) 31 :90 –1 . doi: 10.3969/j.jssn.1672-0369.2019.04.042
17.Gong QL Zhang JM . Effects of electromyographic biofeedback and suspension exercise training on walking function in patients with lower limb spasticity following spinal cord injury . China Med Guide . (2021 ) 18 :110 –3 . doi: 10.20047/j.jssn.1673-7210.2021.02.028
18.Guo Y Gao F Li J Yang M Li J Yang D . Effect of electromyographic biofeedback training on motor function of quadriceps femoris in patients with incomplete spinal cord injury: a randomized controlled trial . NeuroRehabilitation . (2021 ) 48 :345 –51 . doi: 10.3233/NRE-201647 , 33814474
19.Yang S Wu BZ . Study on electromyographic biofeedback electrical stimulation improving lower limb function and walking ability in spinal cord injury patients . Mod Med Health Res . (2023 ) 7 :48 –51 . doi: 10.3969/j.jssn.2096-3718.2023.24.015
20.Chen X Zhang H . Observation on the combined treatment of electromyographic biofeedback and unstable plane core stability training for spinal cord injury patients . Chin J Health Preserv . (2024 ) 42 :66 –9 .
21.Yu B Zhou T Wu J Wang HL Tian Y Zhang DJ . Effects of electromyographic biofeedback combined with rehabilitation training on lower limb muscle strength and gait in patients with incomplete spinal cord injury . J Clin Orthop . (2020 ) 23 :618 –21 . doi: 10.3969/j.issn.1008-0287.2020.05.004
22.Zhang H . Application of electromyographic biofeedback therapy combined with core muscle training in the rehabilitation of patients with incomplete spinal cord injury . Heilongjiang Med J . (2022 ) 46 :471 –3 . doi: 10.3969/j.jssn.1004-5775.2022.04.031
23.dos Santos PP Haselstrom D dos Santos Rocha T Zardo F Aita JSB Goldhardt MG . Comparison of muscular activity on ergometric bicycle and elliptical trainer in subjects with incomplete spinal cord injury . Fisioter Mov . (2023 ) 36 :e36131 . doi: 10.1590/fm.2023.36131
24.Jensen MP Barber J Romano JM Hanley MA Raichle KA Molton IR . Effects of self-hypnosis training and EMG biofeedback relaxation training on chronic pain in persons with spinal-cord injury . Int J Clin Exp Hypn . (2009 ) 57 :239 –68 . doi: 10.1080/00207140902881007 , 19459087 PMC2730649
25.El Semary M Zakria H Youssef Balawy Y Abdel-Azim M . Efficacy of biofeedback training on bladder dysfunction and quality of life in paraplegic patients . Int J PharmTech Res . (2016 ) 9 :799 –805 . doi: 10.1136/acupmed-2016-011225
26.Yang TY Tang H Hu KH Chang YJ Zhang YD Li YA . Effects of operant electromyographic biofeedback therapy combined with rehabilitation training on muscle strength and functional independence in patients with thoracolumbar incomplete spinal cord injury . Jilin Med J . (2017 ) 38 :70 –3 .
27.Chopp M Zhang ZG . Thymosin beta4 as a restorative/regenerative therapy for neurological injury and neurodegenerative diseases . Expert Opin Biol Ther . (2015 ) 15 Suppl 1 :S9 –S12 . doi: 10.1517/14712598.2015.1005596 , 25613458
28.Edmiston T Dean J Wu S Sadowsky C . Pediatric spinal cord injury: overview of clinical and rehabilitative management . Phys Med Rehabil Clin N Am . (2025 ) 36 :499 –512 . doi: 10.1016/j.pmr.2025.03.014 40581436
29.Duarte-Moreira RJ Castro KV Luz-Santos C Martins JVP Sá KN Baptista AF . Electromyographic biofeedback in motor function recovery after peripheral nerve injury: an integrative review of the literature . Appl Psychophysiol Biofeedback . (2018 ) 43 :247 –57 . doi: 10.1007/s10484-018-9403-7 , 30168003
30.Jochumsen M Navid MS Rashid U Haavik H , Niazi IK.EMG- Versus EEG-triggered electrical stimulation for inducing corticospinal plasticity . IEEE Trans Neural Syst Rehabil Eng (2019 ) 27 :1901 –1908 . doi:10.1109/TNSRE.2019.2932104 , 31380763 .
31.Feng X Lv J Li M Lv T Wang S . Short-term efficacy and mechanism of electrical pudendal nerve stimulation versus pelvic floor muscle training plus Transanal electrical stimulation in treating Postradical prostatectomy urinary incontinence . Urology . (2022 ) 160 :168 –75 . doi: 10.1016/j.urology.2021.04.069 , 34284006
32.Petrofsky JS . The use of electromyogram biofeedback to reduce Trendelenburg gait . Eur J Appl Physiol . (2001 ) 85 :491 –5 . doi: 10.1007/s004210100466 , 11606020
33.Eslamian F Jahanjoo F Dolatkhah N Pishgahi A Pirani A . Relative effectiveness of electroacupuncture and biofeedback in the treatment of neck and upper Back myofascial pain: a randomized clinical trial . Arch Phys Med Rehabil . (2020 ) 101 :770 –80 . doi: 10.1016/j.apmr.2019.12.009 , 31954696
34.Caron-Trahan R Jusseaux AE Aubin M Urbanowicz R Richebé P Ogez D . Definition and refinement of HYlaDO, a self-hypnosis training program for chronic pain management: a qualitative exploratory study . Explore (NY) . (2023 ) 19 :417 –25 . doi: 10.1016/j.explore.2022.08.008 , 36008274
35.Jiang W Zhang MS Tan BT Yan Y Jia GW Yi LH . Clinical study on pelvic floor muscle biofeedback electrical stimulation for neurogenic bladder function recovery after spinal cord injury . J Third Mil Med Univ . (2014 ) 36 :1725 –8 . doi: 10.16016/j.1000-5404.2014.16.017
36.Andreopoulou G Busselli G Street T Bulley C Safari R van der Linden ML . Is functional electrical stimulation effective in improving walking in adults with lower limb impairment due to an upper motor neuron lesion? An umbrella review . Artif Organs . (2024 ) 48 :210 –31 . doi: 10.1111/aor.14563 37259954
37.Valera-Sapena F Bravo-Aparicio J Serrano-Muñoz D Pérez-Nombela S Avendaño-Coy J Gómez-Soriano J . Effectiveness of transcranial magnetic stimulation on gait and spasticity in people with spinal cord injury: a systematic review and meta-analysis . Spinal Cord . (2026 ) 64 :303 –16 . doi: 10.1038/s41393-026-01193-2 , 41845072
38.Mehrholz J Kugler J Pohl M . Locomotor training for walking after spinal cord injury . Cochrane Database Syst Rev . (2012 ) 2012 :CD006676 . doi: 10.1002/14651858.CD006676.pub3 , 18425962
39.De Biase KH Politti F Palomari ET Barros-Filho TE De Camargo OP . Increased EMG response following electromyographic biofeedback treatment of rectus femoris muscle after spinal cord injury . Physiotherapy . (2011 ) 97 :175 –9 . doi: 10.1016/j.physio.2010.05.005 21497253
Come citare questo studio
Liu MW, Liu ZY, Zhang BC, Gao SJ, Peng HD. (2026). Electromyography biofeedback therapy for spinal cord injury rehabilitation: a systematic review.. Frontiers in neurology. DOI: 10.3389/fneur.2026.1885605
Consulta la pubblicazione originale ↗